M

Microba Life Sciences Ltd
ASX:MAP

Watchlist Manager
Microba Life Sciences Ltd
ASX:MAP
Watchlist
Price: 0.076 AUD
Market Cap: 46.3m AUD

Microba Life Sciences Ltd
Selling, General & Administrative

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Microba Life Sciences Ltd
Selling, General & Administrative Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
M
Microba Life Sciences Ltd
ASX:MAP
Selling, General & Administrative
-AU$21.2m
CAGR 3-Years
-27%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Sonic Healthcare Ltd
ASX:SHL
Selling, General & Administrative
-AU$5.2B
CAGR 3-Years
-6%
CAGR 5-Years
-7%
CAGR 10-Years
-7%
Integral Diagnostics Ltd
ASX:IDX
Selling, General & Administrative
-AU$439m
CAGR 3-Years
-25%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Capitol Health Ltd
ASX:CAJ
Selling, General & Administrative
-AU$169.6m
CAGR 3-Years
-13%
CAGR 5-Years
-8%
CAGR 10-Years
-9%
Australian Clinical Labs Ltd
ASX:ACL
Selling, General & Administrative
-AU$342.2m
CAGR 3-Years
0%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
H
Healius Ltd
ASX:HLS
Selling, General & Administrative
-AU$791.8m
CAGR 3-Years
10%
CAGR 5-Years
3%
CAGR 10-Years
1%
No Stocks Found

Microba Life Sciences Ltd
Glance View

Market Cap
46.3m AUD
Industry
Health Care

Microba Life Sciences is a precision microbiome science company powering medical innovation to transform human health. The company is headquartered in Brisbane, Queensland. The company went IPO on 2022-04-05. The firm specializes in the analysis of gut microbiome and promotes development in pathology services, therapeutics and diagnostics based on the microbiome. The firm's flagship product is the Microba Insight, a sampling kit that allows the public to analyze personal gut microbiome. Its discovery platform uses human data and informatic approaches to connect microbial genotype to human phenotype. The company also offers support solutions to researchers.

MAP Intrinsic Value
0.242 AUD
Undervaluation 69%
Intrinsic Value
Price
M

See Also

What is Microba Life Sciences Ltd's Selling, General & Administrative?
Selling, General & Administrative
-21.2m AUD

Based on the financial report for Jun 30, 2025, Microba Life Sciences Ltd's Selling, General & Administrative amounts to -21.2m AUD.

What is Microba Life Sciences Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-25%

Over the last year, the Selling, General & Administrative growth was -33%. The average annual Selling, General & Administrative growth rates for Microba Life Sciences Ltd have been -27% over the past three years , -25% over the past five years .

Back to Top